Inhibition of 5-hydroxytryptamine reuptake by the antidepressant citalopram in the locus coeruleus modulates the rat brain noradrenergic transmissionin vivo
Y. Mateo et al., Inhibition of 5-hydroxytryptamine reuptake by the antidepressant citalopram in the locus coeruleus modulates the rat brain noradrenergic transmissionin vivo, NEUROPHARM, 39(11), 2000, pp. 2036-2043
The in vivo effect of the serotonin (5-HT) reuptake inhibitor antidepressan
t citalopram, administered in the locus coeruleus (LC), on noradrenergic tr
ansmission was evaluated in the rat brain. In dual-probe microdialysis assa
ys, citalopram (0.1-100 mu M), in a concentration-dependent manner, increas
ed extracellular noradrenaline (NA) in the LC and simultaneously decreased
extracellular NA in the cingulate cortex (Cg). These effects of citalopram
were abolished by pretreatment with the 5-HT synthesis inhibitor p-chloroph
enylalanine (400 mg/kg, i.p.). When the alpha(2)-adrenoceptor antagonist RS
79948 (1 mu M) was perfused in the LC, local citalopram increased NA dialys
ate in the LC but no longer modified NA dialysate in the Cg. In electrophys
iological experiments, the administration of citalopram (100 mu M) in the L
C by reversal dialysis, decreased the firing rate of LC neurones. The resul
ts demonstrate in vivo that local administration of citalopram in the LC le
ads to a decreased release of NA in the Cg. This modulation seems to be the
result of an increase in NA concentration in the LC and the subsequent inh
ibition of LC neurones via alpha(2)-adrenoceptors. The effects of citalopra
m are dependent on the presence of endogenous 5-HT in the LC. (C) 2000 Else
vier Science Ltd. All rights reserved.